Contents
Academic literature on the topic 'Antihypertenseur central'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Antihypertenseur central.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Antihypertenseur central"
Pasche, Feihl, Liaudet, and Waeber. "Mesure non-invasive de la pression artérielle centrale: comment et pourquoi?" Praxis 96, no. 29 (July 1, 2007): 1137–40. http://dx.doi.org/10.1024/1661-8157.96.29.1137.
Full textBarbeau, Gilles. "La sexualité de la personne âgée et les médicaments." Santé mentale au Québec 5, no. 2 (June 2, 2006): 137–46. http://dx.doi.org/10.7202/030083ar.
Full textDissertations / Theses on the topic "Antihypertenseur central"
Morel, Philippe. "Guanfacine et analogues." Paris 5, 1992. http://www.theses.fr/1992PA05P060.
Full textDurand, Gbezo Evelyne. "Les antihypertenseurs centraux de seconde génération." Paris 5, 1994. http://www.theses.fr/1994PA05P129.
Full textMarc, Yannick. "Analyse des propriétés pharmacologiques des inhibiteurs de l'aminopeptidase A, comme agents antihypertenseurs à action centrale." Paris 5, 2011. http://www.theses.fr/2011PA05P617.
Full textSy, Guata Yoro. "Implication du monoxyde d'azote endogène (NO) et des canaux potassiques de type Girk dans la régulation centrale de la fonction cardiovasculaire : effets des anti-hypertenseurs centraux." Strasbourg 1, 2003. http://www.theses.fr/2003STR13197.
Full textThe aim of this study was to investigate the roles of nitric oxide (NO) and the G-protein inwardly rectifier potassium channel (GIRK) in the central cardiovascular effects of imidazolines and catecholamines. The experiments were performed in pentobarbital anaesthetized rabbits and the drugs were either administered intacisternally or micro-injected into the nucleus reticularis lateralis (NRL) and/or the nucleus tractus solitarii (NTS). The cardiovascular effects of drugs which act on the alpha2-adrenoceptors (a2-AR) of NTS influence a NTS/NRL neuronal GABAergic pathway. The activity of this pathway is dependent of NO. On the opposite, the effects obtained after NRL imidazoline receptor (I1R) stimulation were independent of NO. Therefore, we have identified a new functionnal criterion which discriminates the central mechanisms of action of the hypotensive effects of imidazolines and catecholamines, i. E the dependence of NO. In addition, we demonstrated that the hypotensive effects of I1R selective drugs involve GIRK channels activation and the opening of these channels reveals the hypotensive effect of alpha-methylnoradrenaline (a-MNA), a catecholamine selective for a2-AR, injected into the same site
VERA-TIBIRICA, EDUARDO. "Discrimination pharmacologique entre les composantes specifiquement imidazolinergique et alpha-adrenergique des actions centrales des antihypertenseurs de type clonidine : etudes in vivo." Université Louis Pasteur (Strasbourg) (1971-2008), 1990. http://www.theses.fr/1990STR13156.
Full text